PLA2R1 and glomerular disorder: The identification of autoantigens such as the M-type phospholipase A2 receptor (PLA2R) has revolutionized our understanding of IMN pathogenesis, with PLA2R being implicated in over 70% of cases and demonstrating near 100% specificity for IMN compared to other glomerular diseases (4–6).